Ignite Creation Date:
2024-05-19 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06418360
Status:
COMPLETED
Last Update Posted:
2024-05-17
First Post:
2024-05-06
Brief Title:
Efficacy of TECAR Therapy in Patients With Knee Osteoarthritis
Sponsor:
Ankara City Hospital Bilkent
Organization:
Ankara City Hospital Bilkent
Study Overview
Official Title:
Evaluation of The Efficacy of TECAR Therapy in Patients With Knee Osteoarthritis
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Objective The aim of the present study was to investigate the treatment efficacy of TECAR therapy a modern application that has been increasingly used in recent years compared to conventional physical therapy applications in the treatment of knee osteoarthritis according to the evaluation of the clinical findings of patients
Methods A total of 54 patients aged between 40 and 75 years were randomly divided into two groups Both groups received CPT Group 2 received TECAR therapy in addition to CPT applied three times a week for two weeks for a total of 6 sessions All patients knee joint range of motion ROM was measured goniometrically isometric quadriceps muscle strength was measured and pain levels were assessed using the Visual Analog Scale VAS and disability levels were assessed using the Western Ontario and McMaster Universities Arthritis Index WOMAC before treatment at the end of treatment at 1 month and at 3 months
Methods A total of 54 patients aged between 40 and 75 years were randomly divided into two groups Both groups received CPT Group 2 received TECAR therapy in addition to CPT applied three times a week for two weeks for a total of 6 sessions All patients knee joint range of motion ROM was measured goniometrically isometric quadriceps muscle strength was measured and pain levels were assessed using the Visual Analog Scale VAS and disability levels were assessed using the Western Ontario and McMaster Universities Arthritis Index WOMAC before treatment at the end of treatment at 1 month and at 3 months
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None